176 related articles for article (PubMed ID: 16596339)
1. Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.
Kim SH; Juhnn YS; Kang S; Park SW; Sung MW; Bang YJ; Song YS
Cell Mol Life Sci; 2006 Apr; 63(7-8):930-8. PubMed ID: 16596339
[TBL] [Abstract][Full Text] [Related]
2. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.
Zhang B; Spandau DF; Roman A
J Virol; 2002 Jan; 76(1):220-31. PubMed ID: 11739687
[TBL] [Abstract][Full Text] [Related]
3. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
Liu L; Zhao X; Pierre SV; Askari A
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
[TBL] [Abstract][Full Text] [Related]
4. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
5. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.
Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM
Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.
Lee SJ; Namkoong S; Kim YM; Kim CK; Lee H; Ha KS; Chung HT; Kwon YG; Kim YM
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2836-46. PubMed ID: 16877565
[TBL] [Abstract][Full Text] [Related]
7. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
8. 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.
Akbulut T; Regner KR; Roman RJ; Avner ED; Falck JR; Park F
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F662-70. PubMed ID: 19570883
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3K/Akt and MEK/ERK dependent signaling.
Jin J; Yuan F; Shen MQ; Feng YF; He QL
Mol Cell Biochem; 2013 Sep; 381(1-2):267-72. PubMed ID: 23749166
[TBL] [Abstract][Full Text] [Related]
10. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib.
Matsuo M; Sakurai H; Ueno Y; Ohtani O; Saiki I
Cancer Sci; 2006 Feb; 97(2):155-62. PubMed ID: 16441427
[TBL] [Abstract][Full Text] [Related]
11. Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism.
Hamdi MM; Mutungi G
J Physiol; 2011 Jul; 589(Pt 14):3623-40. PubMed ID: 21606113
[TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2.
Sako K; Fukuhara S; Minami T; Hamakubo T; Song H; Kodama T; Fukamizu A; Gutkind JS; Koh GY; Mochizuki N
J Biol Chem; 2009 Feb; 284(9):5592-601. PubMed ID: 19106103
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.
Kumar P; Miller AI; Polverini PJ
J Biol Chem; 2004 Oct; 279(41):43352-60. PubMed ID: 15292252
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
15. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
Tandon M; Chen Z; Pratap J
J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
[TBL] [Abstract][Full Text] [Related]
16. Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.
He P; Shen N; Gao G; Jiang X; Sun H; Zhou D; Xu N; Nong L; Ren K
Cell Physiol Biochem; 2016; 39(4):1281-94. PubMed ID: 27606614
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia enhances FGF2- and VEGF-stimulated human placental artery endothelial cell proliferation: roles of MEK1/2/ERK1/2 and PI3K/AKT1 pathways.
Wang K; Jiang YZ; Chen DB; Zheng J
Placenta; 2009 Dec; 30(12):1045-51. PubMed ID: 19892399
[TBL] [Abstract][Full Text] [Related]
18. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
19. The papillomavirus E5 gene does not affect EGFR transcription and overall survival in cervical cancer.
Basto DL; Chaves CBP; Felix SP; Amaro-Filho SM; Vieira VC; Martins LFL; de Carvalho NA; Almeida LM; Moreira MÂM
J Med Virol; 2020 Aug; 92(8):1283-1289. PubMed ID: 31696949
[TBL] [Abstract][Full Text] [Related]
20. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.
Menu E; Kooijman R; Van Valckenborgh E; Asosingh K; Bakkus M; Van Camp B; Vanderkerken K
Br J Cancer; 2004 Mar; 90(5):1076-83. PubMed ID: 14997210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]